Jump to navigation Jump to search

WikiDoc Resources for Dermatofibrosarcoma


Most recent articles on Dermatofibrosarcoma

Most cited articles on Dermatofibrosarcoma

Review articles on Dermatofibrosarcoma

Articles on Dermatofibrosarcoma in N Eng J Med, Lancet, BMJ


Powerpoint slides on Dermatofibrosarcoma

Images of Dermatofibrosarcoma

Photos of Dermatofibrosarcoma

Podcasts & MP3s on Dermatofibrosarcoma

Videos on Dermatofibrosarcoma

Evidence Based Medicine

Cochrane Collaboration on Dermatofibrosarcoma

Bandolier on Dermatofibrosarcoma

TRIP on Dermatofibrosarcoma

Clinical Trials

Ongoing Trials on Dermatofibrosarcoma at Clinical

Trial results on Dermatofibrosarcoma

Clinical Trials on Dermatofibrosarcoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dermatofibrosarcoma

NICE Guidance on Dermatofibrosarcoma


FDA on Dermatofibrosarcoma

CDC on Dermatofibrosarcoma


Books on Dermatofibrosarcoma


Dermatofibrosarcoma in the news

Be alerted to news on Dermatofibrosarcoma

News trends on Dermatofibrosarcoma


Blogs on Dermatofibrosarcoma


Definitions of Dermatofibrosarcoma

Patient Resources / Community

Patient resources on Dermatofibrosarcoma

Discussion groups on Dermatofibrosarcoma

Patient Handouts on Dermatofibrosarcoma

Directions to Hospitals Treating Dermatofibrosarcoma

Risk calculators and risk factors for Dermatofibrosarcoma

Healthcare Provider Resources

Symptoms of Dermatofibrosarcoma

Causes & Risk Factors for Dermatofibrosarcoma

Diagnostic studies for Dermatofibrosarcoma

Treatment of Dermatofibrosarcoma

Continuing Medical Education (CME)

CME Programs on Dermatofibrosarcoma


Dermatofibrosarcoma en Espanol

Dermatofibrosarcoma en Francais


Dermatofibrosarcoma in the Marketplace

Patents on Dermatofibrosarcoma

Experimental / Informatics

List of terms related to Dermatofibrosarcoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]


Dermatofibrosarcoma protuberans (DFSP)[1] is a rare tumor. There is only about 1 case per million per year. DFSP is a sarcoma, more precisely a cutaneous soft tissue sarcoma.


About 90% of DFSPs are low grade sarcomas. About 10% are mixed; they contain a high-grade sarcomatous component (DFSP-FS); therefore, they are considered to be intermediate-grade sarcomas. All DFSPs rarely lead to a metastasis (fewer than 5% do metastasise), but DFSPs can recur locally. DFSPs most often arise in patients who are in their thirties, but sometimes have been described in children or the elderly.


The standard of care for patients with DFSP is surgery. Usually, complete surgical resection with wide margins is performed. The addition of adjuvant radiotherapy (irradiation) improves local control in patients with close or positive margins during the surgery. A special surgical technique, the "Mohs micrographic surgery" (MMS), can be employed in patients with DFSP. MMS is technically possible if the DFSP is in an anatomically confined area. A high probability of cure of DFSP can be attained with MMS as long as the final margins are negative. [2] Patients who have a recurrent DFSP can have further surgery, but the probability of adverse effects of surgery and/or metastasis is increased in these patients.

Imatinib is a so-called "biologic", i.e. a newer medicinal drug. As all medicinal drugs which have a name that ends on -ib, imatinib is a small molecular pathway inhibitor; imatinib inhibits tyrosine kinase. It may be able to induce tumor regression in patients with recurrent DFSP, unresectable DFSP or metastatic DFSP.


  1. Mendenhall WM, Zlotecki RA, Scarborough MT.Dermatofibrosarcoma protuberans. Cancer. 2004 Dec 1;101(11):2503-8. Review. [1]
  2. Gloster HM Jr, Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996 Jul;35(1):82-7.

Template:WikiDoc Sources